Pancreatic Cancer Research

ResearcherKyushu UniversityNo recent work listed

Shinjiro Nagao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8335-7253; OpenAlex author ID A5039460386. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

  1. C4orf47 contributes to the dormancy of pancreatic cancer under hypoxic conditions. Co-author DOI 10.7150/jca.78993↗
  2. TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer. First author DOI 10.21873/anticanres.15205↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hideya Onishi · 2 shared papers, 2021–2023 · strength 0.27
  2. Yoshinao Oda · 1 shared paper, 2023 · strength 0.15
  3. Makoto Kawamoto · 1 shared paper, 2023 · strength 0.15
  4. Masafumi Nakamura · 1 shared paper, 2023 · strength 0.15
  5. Akira Imaizumi · 1 shared paper, 2023 · strength 0.15
  6. Akio Yamasaki · 1 shared paper, 2021 · strength 0.12
  7. Yasuhiro Oyama · 1 shared paper, 2021 · strength 0.12
  8. Takashi Morisaki · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.